CCL5 and acute kidney injury: Increased expression of RANTES, CC-chemokine ligand 5 (CCL5), has been reported in various kidney disorders and its inhibition might be an important mechanism for treatment of acute kidney injury, renal transplant rejection, and chronic kidney insufficiency.